New aspects of paradoxical embolism

Vasa - Journal of Vascular Diseases

Volumn 40, Issue 1, 2011, Pages 31-40

  Lehmeyer, S ^a   Lindhoff Last, Edelgard ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Coagulation disorders; Cryptogenic stroke; Endovascular closure; Paradoxical embolism; Patent foramen ovale

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; WARFARIN;

ANTICOAGULANT THERAPY; BLOOD CLOTTING DISORDER; DISEASE ASSOCIATION; HEART RIGHT LEFT SHUNT; HUMAN; MIGRAINE; PARADOXICAL EMBOLISM; PATENT FORAMEN OVALE; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; REVIEW; STROKE; THROMBOCYTE AGGREGATION INHIBITION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VALSALVA MANEUVER;

BLOOD COAGULATION; EMBOLISM, PARADOXICAL; EVIDENCE-BASED MEDICINE; FORAMEN OVALE, PATENT; HEMODYNAMICS; HUMANS; MIGRAINE DISORDERS; PRACTICE GUIDELINES AS TOPIC; RECURRENCE; RISK FACTORS; STROKE; TREATMENT OUTCOME;

EID: 79251606299     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526/a000067     Document Type: Review

References (44)

1. Adams HP, Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24 (1): 35-41.
2. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6 Suppl): 630S-69S.
3. Almekhlafi MA, Wilton SB, Rabi DM, Ghali WA, Lorenzetti DL, Hill MD. Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis. Neurology 2009; 73 (2): 89-97.
4. Anzola GP, Frisoni GB, Morandi E, Casilli F, Onorato E. Shunt-associated migraine responds favorably to atrial septal repair: a case-control study. Stroke 2006; 37 (2): 430-4. (Pubitemid 43732000)
5. Braun M, Gliech V, Boscheri A, Schoen S, Gahn G, Reichmann H, et al. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J 2004; 25 (5): 424-30.
6. Butera G, Biondi-Zoccai GG, Carminati M, Caputi L, Usai S, Bussone G, et al. Systematic review and meta-analysis of currently available clinical evidence on migraine and patent foramen ovale percutaneous closure: much ado about nothing? Catheter Cardiovasc Interv 2010; 75 (4): 494-504.
7. Cabanes L, Mas JL, Cohen A, Amarenco P, Cabanes PA, Oubary P, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993; 24 (12): 1865-73.
8. Cramer SC, Rordorf G, Maki JH, Kramer LA, Grotta JC, Burgin WS, et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke 2004; 35 (1): 46-50.
9. Dearani JA, Ugurlu BS, Danielson GK, Daly RC, McGregor CG, Mullany CJ, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999; 100 (19 Suppl): II171-II175.
10. Diaz CO, Bueno H, Nebreda LA. Acute myocardial infarction caused by paradoxical tumorous embolism as a manifestation of hepatocarcinoma. Heart 2004; 90 (5): e29.
11. Diener HC, Putzki N, Berlit P. Leitlinien für Diagnostik und Therapie in der Neurologie. [4. überarbeitete Auflage]. 2008. S. 654 ff, Georg Thieme Verlag Stuttgart.
12. Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, et al. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008; 117 (11): 1397-404.
13. Droste DW, Kriete JU, Stypmann J, Castrucci M, Wichter T, Tietje R, et al. Contrast transcranial Doppler ultrasound in the detection of right-to-left shunts: comparison of different procedures and different contrast agents. Stroke 1999; 30 (9): 1827-32.
14. Eichhorn V, Bender A, Reuter DA. Paradoxical air embolism from a central venous catheter. Br J Anaesth 2009; 102 (5): 717-8.
15. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 2007; 357 (22): 2262-8.
16. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002; 105 (22): 2625-31.
17. Johnson BI. Paradoxical embolism. J Clin Pathol 1951; 4 (3): 316-32.
18. Karttunen V, Hiltunen L, Rasi V, Vahtera E, Hillbom M. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale. Blood Coagul Fibrinolysis 2003; 14 (3): 261-8.
19. Krumsdorf U, Keppeler P, Horvath K, Zadan E, Schrader R, Sievert H. Catheter closure of atrial septal defects and patent foramen ovale in patients with an atrial septal aneurysm using different devices. J Interv Cardiol 2001; 14 (1): 49-55.
20. Lagattolla NR, Sandison AJ, Smith K, Cochrane GM, Chambers J, Taylor PR. Acute limb ischaemia due to paradoxical embolism from a long-term central venous catheter. Eur J Vasc Endovasc Surg 1998; 16 (4): 365-6.
21. Lamy C, Giannesini C, Zuber M, Arquizan C, Meder JF, Trystram D, et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm. Stroke 2002; 33 (3): 706-11.
22. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988; 318 (18): 1148-52.
23. Li QZ, Yao F, Yang LX, Xu ZY. Paradoxical brain embolism caused by pulmonary arteriovenous fistula. Thorac Cardiovasc Surg 2009; 57 (6): 373-5.
24. Luermans JG, Post MC, Temmerman F, Thijs V, Schonewille WJ, Plokker HW, et al. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine: a prospective observational study. Acta Cardiol 2008; 63 (5): 571-7.
25. Mangiafico S, Scandura S, Ussia GP, Privitera A, Capodanno D, Petralia A, et al. Transesophageal echocardiography and transcranial color Doppler: independent or complementary diagnostic tests for cardiologists in the detection of patent foramen ovale? J Cardiovasc Med (Hagerstown) 2009; 10 (2): 143-8.
26. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001; 345 (24): 1740-6.
27. Miyabe H, Ohte N, Kurokawa K, Goto T, Takada N, Yajima K, et al. Paradoxical brain embolism caused by pulmonary arteriovenous fistula and coincident pulmonary embolism - a case report. Angiology 2004; 55 (5): 577-81. (Pubitemid 39237928)
28. Morandi E, Anzola GP, Angeli S, Melzi G, Onorato E. Transcatheter closure of patent foramen ovale: a new migraine treatment? J Interv Cardiol 2003; 16 (1): 39-42.
29. O'Gara PT, Messe SR, Tuzcu EM, Catha G, Ring JC. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation. Circulation 2009; 119 (20): 2743-7.
30. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000; 55 (8): 1172-9.
31. Pezzini A, Del ZE, Magoni M, Costa A, Archetti S, Grassi M, et al. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke 2003; 34 (1): 28-33.
32. Pezzini A, Grassi M, Zotto ED, Giossi A, Volonghi I, Costa P, et al. Do common prothrombotic mutations influence the risk of cerebral ischaemia in patients with patent foramen ovale? Systematic review and meta-analysis. Thromb Haemost 2009; 101 (5): 813-7.
33. Rigatelli G, Dell'Avvocata F, Giordan M, Camerotto A, Panin S, Ronco F, et al. Safety and long-term results of patent foramen ovale transcatheter closure in patients with thrombophilia. Minerva Cardioangiol 2009; 57 (3): 285-9.
34. Rigatelli G, Dell'Avvocata F, Ronco F, Cardaioli P, Giordan M, Braggion G, et al. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism. JACC Cardiovasc Interv 2010; 3 (3): 282-7.
35. Ringleb P, Schellinger PD, Hacke W. [European Stroke Organisation 2008 guidelines for managing acute cerebral infarction or transient ischemic attack. Part 1]. Nervenarzt 2008; 79 (8): 936-57.
36. Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989; 25 (4): 382-90.
37. Salem DN, O'Gara PT, Madias C, Pauker SG. Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6 Suppl): 593S-629S.
38. Spies C, Khandelwal A, Timmemanns I, Kavinsky CJ, Schrader R, Hijazi ZM. Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism. Catheter Cardiovasc Interv 2008; 72 (7): 966-70.
39. Steiner MM, Di Tullio MR, Rundek T, Gan R, Chen X, Liguori C, et al. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 1998; 29 (5): 944-8.
40. Thienpont E, Kaddar S, Morrison S. Paradoxical fat embolism aft er uncemented total hip arthroplasty: a case report. Acta Orthop Belg 2007; 73 (3): 418-20.
41. Wilmshurst P, Nightingale S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci (Lond) 2001; 100 (2): 215-20.
42. Wilmshurst P, Nightingale S. The role of cardiac and pulmonary pathology in migraine: a hypothesis. Headache 2006; 46 (3): 429-34.
43. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000; 356 (9242): 1648-51.
44. Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C, et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004; 44 (4): 750-8.